Capital Advisors Ltd’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1K Hold
2
– – ﹤0.01% 1387
2026
Q2
$1K Hold
2
– – ﹤0.01% 1263
2026
Q1
$1K Hold
2
– – ﹤0.01% 1255
2025
Q4
$1K Hold
2
– – ﹤0.01% 1232
2025
Q3
$1K Hold
2
– – ﹤0.01% 1234
2025
Q2
$1K Hold
2
– – ﹤0.01% 1222
2025
Q1
$1K Hold
2
– – ﹤0.01% 1222
2024
Q4
$1K Hold
2
– – ﹤0.01% 1249
2024
Q3
$1K Sell
2
-1
-33% -$380 ﹤0.01% 1241
2024
Q2
$1K Buy
3
+1
+50% +$396 ﹤0.01% 1234
2024
Q1
$1K Hold
2
– – ﹤0.01% 1220
2023
Q4
$1K Hold
2
– – ﹤0.01% 1173
2023
Q3
$0 Hold
2
– – ﹤0.01% 1393
2023
Q2
$0 Hold
2
– – ﹤0.01% 1443
2023
Q1
$0 Hold
2
– – ﹤0.01% 1410
2022
Q4
$0 Buy
2
+1
+100% +$200 ﹤0.01% 1470
2022
Q3
$0 Buy
+1
New +$160 ﹤0.01% 1397
2022
Q2
– Sell
-2
Closed – – 1191
2022
Q1
$0 Buy
+2
New +$330 ﹤0.01% 1094

Other funds holding MEDP

Capital Advisors Ltd's MEDP Position: Q3 2026 in Review

Capital Advisors Ltd held its Medpace (MEDP) position steady in Q3 2026 at 2 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1387.

Capital Advisors Ltd first reported a position in MEDP in Q1 2022 and has held it in 18 quarters since. 759 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Capital Advisors Ltd held 2 shares of Medpace worth $1K as of Q3 2026.
  • Capital Advisors Ltd left its Medpace share count unchanged in Q3 2026.
  • Medpace made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q3 2026, its #1387 holding.
  • Capital Advisors Ltd first reported a position in Medpace in Q1 2022 and has held it in 18 quarters since.
  • 759 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Capital Advisors Ltd's 13F filing for Q3 2026, filed 27 Oct 2026.